Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02672475
Title Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Triple Negative Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Vanderbilt-Ingram Cancer Center
Indications

triple-receptor negative breast cancer

Therapies

Galunisertib + Paclitaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.